Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 711M | 844M | 868M | 793M |
Cost of revenue | 695M | 840M | 849M | 798M |
Gross profit | 16M | 4M | 19M | -5M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3M | 5M | 6M | 8M |
Other operating expenses | — | 1M | — | — |
Operating income | 8M | -2M | 13M | -13M |
Non operating interest income | ||||
Income | -5M | — | 4M | 2M |
Expense | 4M | 17M | 9M | 13M |
Other income expense | — | — | — | — |
Pretax income | -11M | -19M | 8M | -24M |
Tax provision | -3M | -5M | 1M | -5M |
Net income | -8M | -14M | 7M | -19M |
Basic EPS | — | -1.1 | 0.6 | -1.5 |
Diluted EPS | — | -1.1 | 0.6 | -1.5 |
Basic average shares | — | 3.6M | 3.3M | 3.6M |
Diluted average shares | — | 3.6M | 3.3M | 3.6M |
EBITDA | 10M | 17M | 32M | 5M |
Net income from continuing op. | -8M | -14M | 7M | -19M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |